Cancer | Cohort (years) | European/Other males | Māori males | Pacific males | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rate | Linear trend p-value | Rate | Linear trend p-value | Rate difference (CI) | Linear trend p-value | Rate ratio (CI) | Rate | Linear trend p-value | Rate difference (CI) | Linear trend p-value | Rate ratio (CI) | ||
Mortality | |||||||||||||
Lung | 1981–84 | 44.5 | . | 87.8 | . | 43.4 (24.4 to 62.4) | . | 1.98 (1.58–2.47) | 23.5 | . | −21.0 (−39.1– −2.9) | . | 0.53 (0.25–1.14) |
2006–11 | 20.5 | <0.01 | 71.2 | 0.07 | 50.7 (42.6–58.8) | 0.87 | 3.47 (3.06–3.94) | 49.9 | 0.30 | 29.4 (17.9–40.9) | 0.07 | 2.43 (1.92–3.08) | |
Colorectal | 1981–84 | 22.5 | . | 13.7 | . | −8.8 (−15.5– −2.2) | . | 0.61 (0.38–0.98) | 7.5 | . | −15.0 (−25.6– −4.4) | . | 0.33 (0.08–1.35) |
2006–11 | 17.4 | 0.05 | 20.4 | 0.15 | 3.1 (−1.1–7.3) | <0.01 | 1.18 (0.96–1.45) | 9.4 | 0.68 | −7.9 (−11.8– −4.0) | 0.10 | 0.54 (0.36–0.81) | |
Prostate | 1981–8 | 9.1 | . | 8.8 | . | −0.3 (−7.6–7.0) | . | 0.97 (0.42–2.21) | 26.2 | . | 17.1 (−14.5–48.6) | . | 2.87 (0.85–9.63) |
2006–11 | 9.3 | 0.86 | 18.5 | 0.01 | 9.2 (4.8–13.7) | <0.01 | 1.99 (1.55–2.56) | 10.0 | 0.23 | 0.7 (−4.7–6.1) | 0.32 | 1.07 (0.62–1.85) | |
Stomach | 1981–84 | 8.7 | . | 24.3 | . | 15.6 (6.2–25.0) | . | 2.80 (1.87–4.20) | 35.2 | . | 26.6 (−1.5–54.6) | . | 4.07 (1.82–9.10) |
2006–11 | 3.8 | <0.01 | 13.2 | 0.15 | 9.4 (6.1–12.7) | 0.57 | 3.47 (2.62–4.59) | 9.7 | 0.04 | 5.8 (1.1–10.6) | 0.07 | 2.53 (1.53–4.18) | |
Melanoma | 1981–84 | 5.6 | . | 0.8 | . | −4.8 (−6.6– −3.1) | . | 0.14 (0.02–0.97) | . | . | . | . | . |
2006–11 | 7.1 | . | 1.9 | . | −5.1 (−6.6– −3.6) | . | 0.28 (0.14–0.54) | 1.6 | . | −5.5 (−7.2– −3.7) | . | 0.23 (0.08–0.61) | |
All cancers | 1981–84 | 147.2 | . | 219.7 | . | 72.5 (43.5–101.4) | . | 1.49 (1.31–1.71) | 173.3 | . | 26.1 (−31.0–83.1) | . | 1.18 (0.85–1.64) |
2006–11 | 112.2 | <0.01 | 214.3 | 0.66 | 102.0 (88.1–116.0) | 0.17 | 1.91 (1.78–2.04) | 148.4 | 0.20 | 36.2 (17.5–54.9) | 0.94 | 1.32 (1.17–1.50) | |
Incidence | |||||||||||||
Lung | 1981–86 | 50.9 | . | 91.2 | . | 40.3 (26.7 to 54.0) | . | 1.79 (1.54 to 2.09) | 56.5 | . | 5.7 (−26.1 to 37.4) | . | 1.11 (0.63 to 1.95) |
2006–11 | 25.6 | <0.01 | 78.9 | 0.08 | 53.3 (44.8 to 61.8) | 0.69 | 3.08 (2.74 to 3.47) | 49.3 | 0.15 | 23.7 (12.3 to 35.2) | 0.70 | 1.93 (1.52 to 2.44) | |
Colorectal | 1981–86 | 48.8 | . | 24.5 | . | −24.3 (−32.1 to −16.4) | . | 0.50 (0.37 to 0.69) | 22.3 | . | −26.5 (−40.1 to −12.9) | . | 0.46 (0.25 to 0.84) |
2006–11 | 47.4 | 0.76 | 42.9 | <0.01 | −4.5 (−10.7 to 1.8) | <0.01 | 0.91 (0.78 to 1.05) | 29.8 | 0.94 | −17.6 (−26.0 to −9.3) | 0.89 | 0.63 (0.48 to 0.83) | |
Prostate | 1981–86 | 27.7 | . | 32.7 | . | 5.0 (−5.5 to 15.5) | . | 1.18 (0.86 to 1.63) | 20.7 | . | −7.0 (−30.0 to 16.0) | . | 0.75 (0.25 to 2.27) |
2006–11 | 110.1 | <0.01 | 101.0 | <0.01 | −9.1 (−18.8 to 0.6) | 0.11 | 0.92 (0.83 to 1.01) | 88.2 | 0.01 | −21.9 (−36.6 to −7.2) | 0.07 | 0.80 (0.68 to 0.95) | |
Stomach | 1981–86 | 11.5 | . | 18.9 | . | 7.4 (1.8 to 13.1) | . | 1.65 (1.21 to 2.24) | 50.1 | . | 38.6 (8.6 to 68.6) | . | 4.37 (2.38 to 8.00) |
2006–11 | 5.5 | <0.01 | 18.7 | 0.44 | 13.2 (9.2 to 17.2) | 0.53 | 3.42 (2.69 to 4.34) | 15.0 | 0.13 | 9.6 (4.2 to 14.9) | 0.31 | 2.75 (1.89 to 3.99) | |
Melanoma | 1981–86 | 21.1 | . | 6.4 | . | −14.7 (−18.0 to −11.5) | . | 0.30 (0.19 to 0.48) | 3.6 | . | −17.5 (−21.8 to −13.2) | . | 0.17 (0.06 to 0.53) |
2006–11 | 53.3 | <0.01 | 8.0 | 0.11 | −45.3 (−48.3 to −42.2) | <0.01 | 0.15 (0.11 to 0.20) | 3.2 | 0.78 | −50.1 (−53.0 to −47.2) | <0.01 | 0.06 (0.03 to 0.12) | |
Liver* | 1981–86 | 1.5 | . | 8.7 | . | 7.3 (3.8 to 10.8) | . | 5.95 (3.73 to 9.51) | 16.3 | . | 14.8 (7.1 to 22.6) | . | 11.12 (6.51 to 19.0) |
2006–11 | 3.8 | 0.01 | 16.5 | 0.02 | 12.8 (9.4 to 16.1) | 0.04 | 4.39 (3.46 to 5.58) | 19.3 | 0.82 | 15.5 (8.9 to 22.1) | 0.64 | 5.12 (3.55 to 7.38) | |
First cancers^ | 1981–86 | 271.2 | . | 309.0 | . | 37.8 (12.2 to 63.3) | . | 1.14 (1.05 to 1.24) | 324.8 | . | 53.6 (−12.7 to 119.9) | . | 1.20 (0.98 to 1.47) |
2006–11 | 401.8 | <0.01 | 427.1 | <0.01 | 25.3 (5.6 to 45.0) | 0.24 | 1.06 (1.01 to 1.11) | 324.2 | 0.47 | −77.6 (−105 to −50.1) | 0.02 | 0.81 (0.74 to 0.88) | |
European/Other females | Māori females | Pacific females | |||||||||||
Cancer | Cohort | Rate | Linear trend p-value | Rate | Linear trend p-value | Rate difference (CI) | Linear trend p-value | Rate ratio (CI) | Rate | Linear trend p-value | Rate difference (CI) | Linear trend p-value | Rate ratio (CI) |
Mortality | |||||||||||||
Lung | 1981–84 | 12.1 | . | 55.7 | . | 43.7 (29.0–58.3) | . | 4.62 (3.49–6.12) | 6.1 | . | −5.9 (−13.1–1.2) | . | 0.51 (0.16–1.62) |
2006–11 | 16.1 | . | 64.6 | . | 48.5 (41.8–55.2) | . | 4.01 (3.56–4.52) | 20.4 | . | 4.3 (−1.5–10.0) | . | 1.26 (0.95–1.68) | |
Colorectal | 1981–84 | 19.3 | . | 6.7 | . | −12.6 (−17.4– −7.8) | . | 0.35 (0.18–0.68) | 3.5 | . | −15.8 (−21.4– −10.2) | . | 0.18 (0.04–0.85) |
2006–11 | 13.6 | . | 11.4 | . | −2.2 (−5.4–1.0) | . | 0.84 (0.64–1.11) | 10.0 | . | −3.6 (−7.7–0.5) | . | 0.74 (0.49–1.11) | |
Breast | 1981–84 | 25.6 | . | 31.3 | . | 5.7 (−4.0–15.3) | . | 1.22 (0.89–1.67) | 18.7 | . | −6.9 (−21.4–7.5) | . | 0.73 (0.34–1.57) |
2006–11 | 18.2 | <0.01 | 37.8 | <0.01 | 19.6 (14.5–24.6) | <0.01 | 2.07 (1.80–2.39) | 27.9 | 0.53 | 9.7 (3.3–16.1) | 0.13 | 1.53 (1.21–1.94) | |
Stomach | 1981–84 | 3.5 | . | 13.3 | . | 9.8 (3.8–15.9) | . | 3.80 (2.33–6.18) | 10.7 | . | 7.2 (−5.3–19.7) | . | 3.05 (0.94–9.89) |
2006–11 | 1.6 | . | 9.4 | . | 7.8 (5.4–10.3) | . | 5.88 (4.26–8.13) | 10.1 | . | 8.5 (4.3–12.6) | . | 6.30 (4.00–9.92) | |
Melanoma | 1981–84 | 3.5 | . | 0.4 | . | −3.1 (−4.2– −2.0) | . | 0.12 (0.02–0.86) | 1.6 | . | −1.9 (−5.2–1.4) | . | 0.46 (0.06–3.31) |
2006–11 | 3.6 | . | 0.9 | . | −2.7 (−3.5– −1.9) | . | 0.25 (0.12–0.51) | 0.7 | . | −2.9 (−4.0– −1.9) | . | 0.19 (0.05–0.76) | |
All cancers^ | 1981–84 | 110.6 | . | 182.8 | . | 72.2 (47.5–97.0) | . | 1.65 (1.44–1.90) | 100.8 | . | −9.8 (−46.3–26.8) | . | 0.91 (0.63–1.31) |
2006–11 | 92.6 | <0.01 | 202.0 | 0.09 | 109.4 (97.4–121.4) | 0.01 | 2.18 (2.05–2.32) | 134.8 | 0.08 | 42.2 (27.4–57.0) | 0.03 | 1.46 (1.30–1.63) | |
Incidence | |||||||||||||
Lung | 1981–86 | 14.9 | . | 45.7 | . | 30.9 (21.4 to 40.3) | . | 3.08 (2.48 to 3.82) | 9.1 | . | −5.7 (−12.0 to 0.5) | . | 0.61 (0.31 to 1.21) |
2006–11 | 21.0 | 0.02 | 74.3 | 0.07 | 53.3 (46.1 to 60.5) | 0.09 | 3.53 (3.17 to 3.94) | 23.4 | 0.03 | 2.4 (−3.9 to 8.6) | 0.07 | 1.11 (0.85 to 1.46) | |
Colorectal | 1981–86 | 43.1 | . | 18.5 | . | −24.6 (−30.0 to −19.2) | . | 0.43 (0.33 to 0.57) | 24.5 | . | −18.5 (−33.0 to −4.0) | . | 0.57 (0.32 to 1.03) |
2006–11 | 37.8 | 0.21 | 24.6 | 0.05 | −13.2 (−17.5 to −8.8) | <0.01 | 0.65 (0.55 to 0.77) | 20.5 | 0.75 | −17.3 (−23.1 to −11.4) | 0.21 | 0.54 (0.41 to 0.72) | |
Breast | 1981–86 | 69.4 | . | 69.1 | . | −0.3 (−10.7 to 10.1) | . | 1.00 (0.86 to 1.16) | 67.5 | . | −1.9 (−22.4 to 18.5) | . | 0.97 (0.72 to 1.32) |
2006–11 | 95.8 | 0.03 | 140.1 | <0.01 | 44.3 (35.2 to 53.4) | <0.01 | 1.46 (1.37 to 1.57) | 116.0 | 0.05 | 20.2 (7.6 to 32.8) | 0.40 | 1.21 (1.09 to 1.35) | |
Stomach | 1981–86 | 4.9 | . | 14.7 | . | 9.8 (5.0 to 14.6) | . | 2.98 (2.10 to 4.22) | 15.9 | . | 11.0 (−1.3 to 23.3) | . | 3.23 (1.47 to 7.07) |
2006–11 | 2.3 | <0.01 | 13.6 | 0.96 | 11.3 (8.4 to 14.2) | 0.32 | 5.84 (4.47 to 7.64) | 8.7 | 0.14 | 6.4 (2.6 to 10.2) | 0.34 | 3.73 (2.35 to 5.93) | |
Melanoma | 1981–86 | 29.2 | . | 6.2 | . | −23.0 (−26.2 to −19.8) | . | 0.21 (0.14 to 0.33) | 4.1 | . | −25.2 (−30.0 to −20.3) | . | 0.14 (0.05 to 0.43) |
2006–11 | 48.8 | <0.01 | 7.7 | 0.23 | −41.1 (−43.8 to −38.4) | <0.01 | 0.16 (0.12 to 0.20) | 2.5 | 0.54 | −46.4 (−48.9 to −43.9) | <0.01 | 0.05 (0.03 to 0.10) | |
Liver* | 1981–86 | 0.9 | . | 6.8 | . | 5.8 (1.1 to 10.5) | . | 7.23 (3.38 to 15.5) | 4.6 | . | 3.7 (−1.5 to 8.9) | . | 4.93 (1.53 to 15.9) |
2006–11 | 1.5 | . | 4.6 | . | 3.1 (1.5 to 4.8) | . | 3.14 (2.08 to 4.74) | 3.8 | . | 2.4 (−0.2 to 4.9) | . | 2.62 (1.32 to 5.22) | |
Cervix* | 1981–86 | 11.9 | . | 39.8 | . | 27.9 (19.6 to 36.2) | . | 3.35 (2.67 to 4.19) | 25.1 | . | 13.2 (1.9 to 24.4) | . | 2.11 (1.34 to 3.32) |
2006–11 | 5.0 | <0.01 | 14.2 | <0.01 | 9.2 (6.4 to 12.0) | 0.03 | 2.84 (2.25 to 3.59) | 9.7 | 0.08 | 4.7 (1.3 to 8.1) | 0.40 | 1.95 (1.35 to 2.81) | |
Endometrial* | 1981–86 | 11.8 | . | 18.6 | . | 6.8 (1.9 to 11.8) | . | 1.58 (1.20 to 2.07) | 22.9 | . | 11.1 (−1.7 to 23.9) | . | 1.94 (1.10 to 3.41) |
2006–11 | 12.6 | 0.25 | 27.5 | 0.17 | 14.9 (10.7 to 19.1) | 0.20 | 2.18 (1.85 to 2.57) | 49.8 | <0.01 | 37.2 (29.1 to 45.3) | <0.01 | 3.95 (3.31 to 4.71) | |
First cancers^ | 1981–86 | 258.0 | . | 308.0 | . | 50.0 (27.0 to 73.0) | . | 1.19 (1.11 to 1.29) | 277.3 | . | 19.2 (−26.3 to 64.8) | . | 1.07 (0.91 to 1.27) |
2006–11 | 344.7 | 0.01 | 419.9 | <0.01 | 75.2 (58.5 to 91.9) | 0.22 | 1.22 (1.17 to 1.27) | 335.1 | 0.09 | −9.6 (−32.0 to 12.9) | 0.33 | 0.97 (0.91 to 1.04) |